SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-17-005627
Filing Date
2017-03-30
Accepted
2017-03-30 16:25:04
Documents
7
Period of Report
2017-05-02
Effectiveness Date
2017-03-30

Document Format Files

Seq Description Document Type Size
1 BIOC-PROXY-2017 bioc-def14a_20170502.htm DEF 14A 1559272
2 GRAPHIC g2017032920453204453134.jpg GRAPHIC 6761
3 GRAPHIC g2017032920455089853137.jpg GRAPHIC 38407
4 GRAPHIC g2017032920453167753132.jpg GRAPHIC 6763
5 GRAPHIC g2017032920454185353135.jpg GRAPHIC 2704
6 GRAPHIC g2017032920453198953133.jpg GRAPHIC 2704
7 GRAPHIC g2017032920455085653136.jpg GRAPHIC 99199
  Complete submission text file 0001564590-17-005627.txt   1776854
Mailing Address 5810 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 5810 NANCY RIDGE DR SAN DIEGO CA 92121 858-320-8200
BIOCEPT INC (Filer) CIK: 0001044378 (see all company filings)

IRS No.: 330757995 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36284 | Film No.: 17726053
SIC: 8071 Services-Medical Laboratories